Telmisartan reduces mortality and left ventricular hypertrophy with sympathoinhibition in rats with hypertension and heart failure. [electronic resource]
Producer: 20140922Description: 260-7 p. digitalISSN:- 1941-7225
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Animals
- Benzimidazoles -- therapeutic use
- Benzoates -- therapeutic use
- Biphenyl Compounds -- therapeutic use
- Heart Failure -- drug therapy
- Hypertension -- drug therapy
- Hypertrophy, Left Ventricular -- drug therapy
- Medulla Oblongata -- drug effects
- Norepinephrine -- urine
- Rats
- Rats, Inbred SHR
- Reactive Oxygen Species -- metabolism
- Telmisartan
- Tetrazoles -- therapeutic use
- Ventricular Function, Left -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.